Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Adrenoleukodystrophy Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Minoryx Therapeutics sl
ReceptoPharm Inc
SOM Biotech SL
Bluebird Bio Inc
Applied Genetic Technologies Corp
Viking Therapeutics Inc
MedDay SA
By Type:
Lenti-D
Others
DRX-065
MIN-102
DUOC-01
OP-101
Biotin
By Application:
Children
Adult
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Adrenoleukodystrophy Drugs Market Overview 2018-2029
-
1.1 China Adrenoleukodystrophy Drugs Industry Development Overview
-
1.2 China Adrenoleukodystrophy Drugs Industry Development History
-
1.3 China Adrenoleukodystrophy Drugs Industry Market Size (2018-2029)
-
1.4 China Adrenoleukodystrophy Drugs Market Analysis by Type from Production Side
-
1.4.1 China Adrenoleukodystrophy Drugs Production Volume, Production Value and Growth Rate of Lenti-D (2018-2029)
-
1.4.2 China Adrenoleukodystrophy Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.3 China Adrenoleukodystrophy Drugs Production Volume, Production Value and Growth Rate of DRX-065 (2018-2029)
-
1.4.4 China Adrenoleukodystrophy Drugs Production Volume, Production Value and Growth Rate of MIN-102 (2018-2029)
-
1.4.5 China Adrenoleukodystrophy Drugs Production Volume, Production Value and Growth Rate of DUOC-01 (2018-2029)
-
1.4.6 China Adrenoleukodystrophy Drugs Production Volume, Production Value and Growth Rate of OP-101 (2018-2029)
-
1.4.7 China Adrenoleukodystrophy Drugs Production Volume, Production Value and Growth Rate of Biotin (2018-2029)
-
1.5 China Adrenoleukodystrophy Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Adrenoleukodystrophy Drugs Sales Volume, Sales Value and Growth Rate of Children (2018-2029)
-
1.5.2 China Adrenoleukodystrophy Drugs Sales Volume, Sales Value and Growth Rate of Adult (2018-2029)
-
1.6 China Adrenoleukodystrophy Drugs Market Analysis by Region
-
1.6.1 North China Adrenoleukodystrophy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Adrenoleukodystrophy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Adrenoleukodystrophy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Adrenoleukodystrophy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Adrenoleukodystrophy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Adrenoleukodystrophy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Adrenoleukodystrophy Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Adrenoleukodystrophy Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Adrenoleukodystrophy Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Adrenoleukodystrophy Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Adrenoleukodystrophy Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Adrenoleukodystrophy Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Adrenoleukodystrophy Drugs Industry Development
Chapter 3 Adrenoleukodystrophy DrugsIndustry Chain Analysis
-
3.1 Adrenoleukodystrophy Drugs Industry Chain
-
3.2 Adrenoleukodystrophy Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Adrenoleukodystrophy Drugs Market
-
3.3 Adrenoleukodystrophy Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Adrenoleukodystrophy Drugs Market
Chapter 4 China Adrenoleukodystrophy Drugs Market, by Type
-
4.1 China Adrenoleukodystrophy Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Adrenoleukodystrophy Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Adrenoleukodystrophy Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Adrenoleukodystrophy Drugs Production Volume and Growth Rate of Lenti-D
-
4.5.2 China Adrenoleukodystrophy Drugs Production Volume and Growth Rate of Others
-
4.5.3 China Adrenoleukodystrophy Drugs Production Volume and Growth Rate of DRX-065
-
4.5.4 China Adrenoleukodystrophy Drugs Production Volume and Growth Rate of MIN-102
-
4.5.5 China Adrenoleukodystrophy Drugs Production Volume and Growth Rate of DUOC-01
-
4.5.6 China Adrenoleukodystrophy Drugs Production Volume and Growth Rate of OP-101
-
4.5.7 China Adrenoleukodystrophy Drugs Production Volume and Growth Rate of Biotin
Chapter 5 China Adrenoleukodystrophy Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Adrenoleukodystrophy Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Adrenoleukodystrophy Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Adrenoleukodystrophy Drugs Market Size and Growth Rate of Children
-
5.5.2 China Adrenoleukodystrophy Drugs Market Size and Growth Rate of Adult
Chapter 6 China Adrenoleukodystrophy Drugs Market, by Region
-
6.1 China Adrenoleukodystrophy Drugs Production Volume and Production Value, by Region
-
6.2 China Adrenoleukodystrophy Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Adrenoleukodystrophy Drugs Market Analysis
-
7.1 North China Adrenoleukodystrophy Drugs Market, by Type
-
7.2 North China Adrenoleukodystrophy Drugs Market, by Application
Chapter 8 Central China Adrenoleukodystrophy Drugs Market Analysis
-
8.1 Central China Adrenoleukodystrophy Drugs Market, by Type
-
8.2 Central China Adrenoleukodystrophy Drugs Market, by Application
Chapter 9 South China Adrenoleukodystrophy Drugs Market Analysis
-
9.1 South China Adrenoleukodystrophy Drugs Market, by Type
-
9.2 South China Adrenoleukodystrophy Drugs Market, by Application
Chapter 10 East China Adrenoleukodystrophy Drugs Market Analysis
-
10.1 East China Adrenoleukodystrophy Drugs Market, by Type
-
10.2 East China Adrenoleukodystrophy Drugs Market, by Application
Chapter 11 Northeast China Adrenoleukodystrophy Drugs Market Analysis
-
11.1 Northeast China Adrenoleukodystrophy Drugs Market, by Type
-
11.2 Northeast China Adrenoleukodystrophy Drugs Market, by Application
Chapter 12 Southwest China Adrenoleukodystrophy Drugs Market Analysis
-
12.1 Southwest China Adrenoleukodystrophy Drugs Market, by Type
-
12.2 Southwest China Adrenoleukodystrophy Drugs Market, by Application
Chapter 13 Northwest China Adrenoleukodystrophy Drugs Market Analysis
-
13.1 Northwest China Adrenoleukodystrophy Drugs Market, by Type
-
13.2 Northwest China Adrenoleukodystrophy Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 Minoryx Therapeutics sl
-
14.1.1 Minoryx Therapeutics sl Company Profile
-
14.1.2 Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 ReceptoPharm Inc
-
14.2.1 ReceptoPharm Inc Company Profile
-
14.2.2 ReceptoPharm Inc Adrenoleukodystrophy Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 SOM Biotech SL
-
14.3.1 SOM Biotech SL Company Profile
-
14.3.2 SOM Biotech SL Adrenoleukodystrophy Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Bluebird Bio Inc
-
14.4.1 Bluebird Bio Inc Company Profile
-
14.4.2 Bluebird Bio Inc Adrenoleukodystrophy Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Applied Genetic Technologies Corp
-
14.5.1 Applied Genetic Technologies Corp Company Profile
-
14.5.2 Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Viking Therapeutics Inc
-
14.6.1 Viking Therapeutics Inc Company Profile
-
14.6.2 Viking Therapeutics Inc Adrenoleukodystrophy Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 MedDay SA
-
14.7.1 MedDay SA Company Profile
-
14.7.2 MedDay SA Adrenoleukodystrophy Drugs Market Performance
-
14.7.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Adrenoleukodystrophy Drugs Industry Research Conclusions
-
15.2 Adrenoleukodystrophy Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Adrenoleukodystrophy Drugs Industry Market Size (2018-2029)
-
Figure China Adrenoleukodystrophy Drugs Production Volume, Production Value and Growth Rate of Lenti-D (2018-2029)
-
Figure China Adrenoleukodystrophy Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Adrenoleukodystrophy Drugs Production Volume, Production Value and Growth Rate of DRX-065 (2018-2029)
-
Figure China Adrenoleukodystrophy Drugs Production Volume, Production Value and Growth Rate of MIN-102 (2018-2029)
-
Figure China Adrenoleukodystrophy Drugs Production Volume, Production Value and Growth Rate of DUOC-01 (2018-2029)
-
Figure China Adrenoleukodystrophy Drugs Production Volume, Production Value and Growth Rate of OP-101 (2018-2029)
-
Figure China Adrenoleukodystrophy Drugs Production Volume, Production Value and Growth Rate of Biotin (2018-2029)
-
Figure China Adrenoleukodystrophy Drugs Sales Volume, Sales Value and Growth Rate of Children (2018-2029)
-
Figure China Adrenoleukodystrophy Drugs Sales Volume, Sales Value and Growth Rate of Adult (2018-2029)
-
Figure North China Adrenoleukodystrophy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Adrenoleukodystrophy Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Adrenoleukodystrophy Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Adrenoleukodystrophy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Adrenoleukodystrophy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Adrenoleukodystrophy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Adrenoleukodystrophy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Adrenoleukodystrophy Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Adrenoleukodystrophy Drugs Market Share by Type in 2018
-
Figure China Adrenoleukodystrophy Drugs Market Share by Type in 2023
-
Figure China Adrenoleukodystrophy Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Adrenoleukodystrophy Drugs Production Volume and Growth Rate of Lenti-D (2018-2023)
-
Figure China Adrenoleukodystrophy Drugs Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Adrenoleukodystrophy Drugs Production Volume and Growth Rate of DRX-065 (2018-2023)
-
Figure China Adrenoleukodystrophy Drugs Production Volume and Growth Rate of MIN-102 (2018-2023)
-
Figure China Adrenoleukodystrophy Drugs Production Volume and Growth Rate of DUOC-01 (2018-2023)
-
Figure China Adrenoleukodystrophy Drugs Production Volume and Growth Rate of OP-101 (2018-2023)
-
Figure China Adrenoleukodystrophy Drugs Production Volume and Growth Rate of Biotin (2018-2023)
-
Figure China Adrenoleukodystrophy Drugs Market Share by Application in 2018
-
Figure China Adrenoleukodystrophy Drugs Market Share by Application in 2023
-
Figure China Adrenoleukodystrophy Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Adrenoleukodystrophy Drugs Market Size and Growth Rate of Children (2018-2023)
-
Figure China Adrenoleukodystrophy Drugs Market Size and Growth Rate of Adult (2018-2023)
-
Table China Adrenoleukodystrophy Drugs Production Volume by Region (2018-2023)
-
Table China Adrenoleukodystrophy Drugs Production Volume Share by Region (2018-2023)
-
Figure China Adrenoleukodystrophy Drugs Production Volume Share by Region (2018-2023)
-
Table China Adrenoleukodystrophy Drugs Production Value by Region (2018-2023)
-
Table China Adrenoleukodystrophy Drugs Production Value Share by Region (2018-2023)
-
Figure China Adrenoleukodystrophy Drugs Production Value Share by Region (2018-2023)
-
Table China Adrenoleukodystrophy Drugs Sales Volume by Region (2018-2023)
-
Table China Adrenoleukodystrophy Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Adrenoleukodystrophy Drugs Sales Volume Share by Region (2018-2023)
-
Table China Adrenoleukodystrophy Drugs Sales Value by Region (2018-2023)
-
Table China Adrenoleukodystrophy Drugs Sales Value Share by Region (2018-2023)
-
Figure China Adrenoleukodystrophy Drugs Sales Value Share by Region (2018-2023)
-
Table North China Adrenoleukodystrophy Drugs Production Volume by Type (2018-2023)
-
Table North China Adrenoleukodystrophy Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Adrenoleukodystrophy Drugs Production Volume Share by Type (2018-2023)
-
Table North China Adrenoleukodystrophy Drugs Sales Volume by Application (2018-2023)
-
Table North China Adrenoleukodystrophy Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Adrenoleukodystrophy Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Adrenoleukodystrophy Drugs Production Volume by Type (2018-2023)
-
Table Central China Adrenoleukodystrophy Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Adrenoleukodystrophy Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Adrenoleukodystrophy Drugs Sales Volume by Application (2018-2023)
-
Table Central China Adrenoleukodystrophy Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Adrenoleukodystrophy Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Adrenoleukodystrophy Drugs Production Volume by Type (2018-2023)
-
Table South China Adrenoleukodystrophy Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Adrenoleukodystrophy Drugs Production Volume Share by Type (2018-2023)
-
Table South China Adrenoleukodystrophy Drugs Sales Volume by Application (2018-2023)
-
Table South China Adrenoleukodystrophy Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Adrenoleukodystrophy Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Adrenoleukodystrophy Drugs Production Volume by Type (2018-2023)
-
Table East China Adrenoleukodystrophy Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Adrenoleukodystrophy Drugs Production Volume Share by Type (2018-2023)
-
Table East China Adrenoleukodystrophy Drugs Sales Volume by Application (2018-2023)
-
Table East China Adrenoleukodystrophy Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Adrenoleukodystrophy Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Adrenoleukodystrophy Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Adrenoleukodystrophy Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Adrenoleukodystrophy Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Adrenoleukodystrophy Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Adrenoleukodystrophy Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Adrenoleukodystrophy Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Adrenoleukodystrophy Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Adrenoleukodystrophy Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Adrenoleukodystrophy Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Adrenoleukodystrophy Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Adrenoleukodystrophy Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Adrenoleukodystrophy Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Adrenoleukodystrophy Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Adrenoleukodystrophy Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Adrenoleukodystrophy Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Adrenoleukodystrophy Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Adrenoleukodystrophy Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Adrenoleukodystrophy Drugs Sales Volume Share by Application (2018-2023)
-
Table Minoryx Therapeutics sl Company Profile
-
Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Revenue, Price and Gross (2018-2023)
-
Table ReceptoPharm Inc Company Profile
-
Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Revenue, Price and Gross (2018-2023)
-
Table SOM Biotech SL Company Profile
-
Table SOM Biotech SL Adrenoleukodystrophy Drugs Revenue, Price and Gross (2018-2023)
-
Table Bluebird Bio Inc Company Profile
-
Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Revenue, Price and Gross (2018-2023)
-
Table Applied Genetic Technologies Corp Company Profile
-
Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Revenue, Price and Gross (2018-2023)
-
Table Viking Therapeutics Inc Company Profile
-
Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Revenue, Price and Gross (2018-2023)
-
Table MedDay SA Company Profile
-
Table MedDay SA Adrenoleukodystrophy Drugs Revenue, Price and Gross (2018-2023)
-
